| 82.96 -4.51 (-5.16%) | 08-06 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 105.11  |
1-year : | 122.78 |
| Resists | First : | 90 |
Second : | 105.11 |
| Pivot price | 83.06 |
|||
| Supports | First : | 80.58 |
Second : | 74.76 |
| MAs | MA(5) : | 86.37 |
MA(20) : | 81.82 |
| MA(100) : | 74.06 |
MA(250) : | 74.97 |
|
| MACD | MACD : | 2.4 |
Signal : | 2.1 |
| %K %D | K(14,3) : | 77.1 |
D(3) : | 86.4 |
| RSI | RSI(14): 52.7 |
|||
| 52-week | High : | 90 | Low : | 62.38 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ SOLV ] has closed above bottom band by 49.4%. Bollinger Bands are 91.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 90.1 - 90.83 | 90.83 - 91.33 |
| Low: | 80.83 - 81.59 | 81.59 - 82.1 |
| Close: | 81.97 - 83.14 | 83.14 - 83.93 |
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
Thu, 06 Aug 2026
Solventum (SOLV) Stock Retreats As Tariff Refund Clouds Underlying Growth - simplywall.st
Thu, 06 Aug 2026
Solventum Corp. stock falls Thursday, underperforms market - MarketWatch
Thu, 06 Aug 2026
Solventum Corporation Stock 12‑Month Price Target Raised to $95, Implies 9% Upside - tradingview.com
Thu, 06 Aug 2026
Solventum Corp (SOLV) (Q2 2026) Earnings Call Highlights: Strong Growth and Strategic ... - Yahoo Finance
Wed, 05 Aug 2026
Solventum Corporation 2026 Q2 - Results - Earnings Call Presentation (NYSE:SOLV) 2026-08-05 - Seeking Alpha
Wed, 05 Aug 2026
Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 173 (M) |
| Shares Float | 147 (M) |
| Held by Insiders | 15 (%) |
| Held by Institutions | 76.3 (%) |
| Shares Short | 4,300 (K) |
| Shares Short P.Month | 5,450 (K) |
| EPS | 8.17 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 28.63 |
| Profit Margin | 17.3 % |
| Operating Margin | 5.5 % |
| Return on Assets (ttm) | 2.7 % |
| Return on Equity (ttm) | 34.7 % |
| Qtrly Rev. Growth | -3 % |
| Gross Profit (p.s.) | 25.58 |
| Sales Per Share | 47.69 |
| EBITDA (p.s.) | 6.46 |
| Qtrly Earnings Growth | -91 % |
| Operating Cash Flow | 151 (M) |
| Levered Free Cash Flow | 378 (M) |
| PE Ratio | 10.15 |
| PEG Ratio | 1.2 |
| Price to Book value | 2.89 |
| Price to Sales | 1.73 |
| Price to Cash Flow | 95.14 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|